Beta Bionics appoints new CMO ahead of artificial pancreas launch
Beta Bionics appointed Dr. Steven Russell as its chief medical officer (CMO) as it readies itself for a major product launch.
Stay updated with breaking news from Beta Bionics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Beta Bionics appointed Dr. Steven Russell as its chief medical officer (CMO) as it readies itself for a major product launch.
Caution: The iLet Bionic Pancreas is an investigational device limited by Federal law to investigational use. Not available for sale....
A roundup of some of 2022’s best facts and findings from The Brink, Boston University’s research news site.
The threshold suspended device systems segment held the major market share among the type segment in the artificial pancreas device systems market
Increasing incidence of diabetes is expected to enhance the growth of artificial pancreas device systems market from 2018 to 2025.